Use of complementary therapies during chemotherapy: Influence of patients' satisfaction with treatment decision making and the treating oncologist

Integrative Cancer Therapies

Volumn 5, Issue 3, 2006, Pages 224-231

  Hann, Danette ^a   Allen, Susan ^b   Ciambrone, Desirée ^c   Shah, Ann ^b  

^a Advanced Research Corporation   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND COLLEGE   (United States)

Author keywords

Breast cancer; Complementary therapy; Patient physician communication; Satisfaction with medical decision making

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DIETARY INTAKE; DOCTOR PATIENT RELATION; EARLY CANCER; FEMALE; HERB; HUMAN; MAJOR CLINICAL STUDY; MENTAL PERFORMANCE; PATIENT DECISION MAKING; PATIENT SATISFACTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; SIDE EFFECT; SPIRITUAL HEALING; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; VITAMIN INTAKE;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; DECISION MAKING; FEMALE; HUMANS; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; TREATMENT OUTCOME;

EID: 33746646721     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735406291494     Document Type: Article

References (58)

1. Abu-Abu-Realh M, Magwood G, Narayan M, Rupprecht C, Suraci M. Use of complementary therapies by cancer patients. Nursingconnections. 1996;9:3-12.
2. Spiegel D, Stroud P, Fyfe A. Complementary medicine. West J Med. 1998;168:241-247.
3. Wyatt GK, Friedman LL, Given CW, Given BA, Beckrow KC. Complementary therapy use among older cancer patients. Cancer Pract. 1999;7:136-144.
4. Adler SR. Complementary and alternative medicine use among women with breast cancer. Med Anthropol Q. 1999;13:214-222.
5. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92:42-47.
6. Standish LJ, Greene K, Greenlee H, Kim JG, Grosshans C, Complementary and alternative medical treatment of breast cancer: a survey of licensed North American naturopathic physicians. Alt Ther Health Med. 2002;8:74-81.
7. VandeCreek L, Rogers E, Lester J. Use of alternative therapies among breast cancer outpatients compared with the general population. Alt Ther Health Med. 1999;5:71-76.
8. Verhoef MJ, White MA, Doll R. Cancer patients' expectations of the role of family physicians in communication about complementary therapies. Cancer Prev Control. 1999;3:181-187.
9. Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol. 2005;23:2590-2592.
10. Targ EF, Levine EG. The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial. Gen Hosp Psychiatry. 2002;24:238-248.
11. Allen S, Shah A, Laliberte L. Problems in doctor-patient communication: the case of younger women with breast cancer. Crit Pub Health. 2001;11:39-58.
12. Bruera E, Willey JS, Palmer JL, Resales M. Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer. 2002;94:2076-2080.
13. Richardson MA, Post-White J, Singletary SE, Justice B. Recruitment for complementary/alternative medicine trials: who participates after breast cancer. Ann Behav Med. 1998;20:190-198.
14. Cassileth BR. Evaluating complementary and alternative therapies for cancer patients. Cancer. 1999;49:362-375.
15. Gotay CC, Hara W, Issell BF, Maskarinec G. Use of complementary and alternative medicine in Hawaii cancer patients. Hawaii Med J. 1999;58:94-98.
16. Yates JS, Mustian KM, Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Cancer Care. 2005;13:806-811.
17. Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000;179:407-411.
18. Tagliaferri M, Cohen I, Tripathy D. Complementary and alternative medicine in early stage breast cancer. Semin Oncol. 2001;28:121-134.
19. Maskarinec G, Shumay DM, Kakai H, Gotay CC. Ethnic differences in complementary and alternative medicine use among cancer patients. J Alt Comp Med. 2000;6:531-538.
20. Verhoef MJ, Hilsden RJ, O'Beirne M. Complementary therapies and cancer care: an overview. Patient Educ Couns. 1999;38:93-100.
21. Crocetti E, Crotti N, Feltrin A, Ponton P, Geddes M, Buiatti E. The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Cancer. 1998;34:324-328.
22. Boon H, Stewart M, Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perception. J Clin Oncol. 2000;18:2515-2521.
23. Ashikaga T, Bosompra K, O'Brien P, Nelson L. Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10:542-548.
24. Lengacher CA, Bennett MP, Kip KE, et al. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum. 2002;29:1445-1452.
25. Hann DM, Baker F, Denniston MM, Entrekin N. Long-term breast cancer survivors' use of complementary therapies: perceived impact on recovery and prevention of recurrence. Integr Cancer Ther. 2005;1:14-20.
26. Hann DM, Baker F, Roberts C, et al. Use of complementary therapies among breast and prostate cancer patients during treatment: a multi-site study. Integr Cancer Ther. 2005;4:294-300.
27. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340:1733-1739.
28. Moschen R, Kemmler G, Schweigkofler H, et al. Use of alternative/ complementary therapy in breast cancer patients - a psychological perspective. Support Care Cancer. 2001;9:267-274.
29. DiGianni LM, Kim HT, Emmons K, Gelman R, Kalkbrenner KJ, Garber JE. Complementary medicine use among women enrolled in a genetic testing program. Cancer Epidemiol Biomarkers Prev. 2003;12:321-326.
30. Rakovitch E, Pignol JP, Chartier C, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat. 2005;90:139-148.
31. Verhoef MJ, Balneaves LG, Boon HS. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther. 2005;4:274-286.
32. Shumay DM, Maskarinec G, Gotay CC, Heiby EM, Kakai H. Determinants of the degree of complementary and alternative medicine use among patients with cancer. J Alt Comp Med. 2002;8:661-671.
33. Balneaves LG, Kristjanson LJ Tataryn D. Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns. 1999;38:143-153.
34. Epstein RM, Campbell TL, Cohen-Cole SA, McWhinney IR, Smilkstein G. Perspectives on patient-doctor communication. J Fam Pract. 1993;37:377-388.
35. Ong L, De Haes J, Hoos A, Lammes E. Doctor-patient communication: a review of the literature. Soc Sci Med. 1995;40:903-918.
36. Roberts CS, Cox CE, Reintgen DS, Baile WF, Gibertini M. Influence of physician communication on newly diagnosed breast patients' psychological adjustment and decision-making. Cancer. 1994;74:336-341.
37. Bennett M, Alison D. Discussing the diagnosis and prognosis with cancer patients. Postgrad Med J. 1996;72:25-29.
38. Frederikson LG. Exploring information-exchange in consultation: the patients' view of performance and outcomes. Patient Educ Couns. 1995;25:237-246.
39. Shapiro DE, Boggs SR, Melamed BG, Graham-Pole J. The effect of varied physician affect on recall, anxiety, and perception in women at risk for breast cancer: an analogue study. Health Psych. 1992;11:61-66.
40. Frankel RM. Emotion and the physician-patient relationship. Motivation and Emotion. 1995;19:163-173.
41. Gilligan T, Raffin TA. Physician virtues and communicating with patients. New Horiz. 1977;5:6-14.
42. Hall JA, Palmer H, Orav EJ, Hargraves L, Wright EA, Louis TA. Performance quality, gender, and professional role: a study of physicians and non-physicians in 16 ambulatory care practices. Med Care. 1990;28:489-501.
43. Osuch JR, Bonham VL. The timely diagnosis of breast cancer: principles of risk management for primary care providers and surgeons. Cancer. 1994;74:271-278.
44. Phillips D. Medical professional dominance and client dissatisfaction: a study of doctor-patient interaction and reported dissatisfaction with medical care among female patients at four hospitals in Trinidad and Tobago. Soc Sci Med. 1996;42:1419-1425.
45. Allen SM, Shah AC, Nezu AM, Ciambrone D, Hogan J, Mor V. A problem-solving approach to stress reduction among younger women with breast carcinoma: a randomized controlled trial. Cancer. 2002;94:3089-3100.
46. American Cancer Society. Guide to Complementary and Alternative Cancer Methods. Atlanta, Ga: American Cancer Society; 2000.
47. National Institutes of Health. Definitions of complementary therapy. 2006. Available at: http://nccam.nih.gov/health.
48. Truant T, Bottorff JL. Decision making related to complementary therapies: a process of regaining control. Patient Educ Couns. 1999;38:131-142.
49. Boon H, Brown JB, Gavin A, Kennard MA, Stewart M. Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res. 1999;9:639-653.
50. Ware JE, Sherbourne CD. The MOS 36-item Short Form Health Survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473-483.
51. Penson RT, Castro CM, Seiden MV, Chabner BA, Lynch TJ. Complementary, alternative, integrative, or unconventional medicine? Oncologist. 2001;6:463-473.
52. Bruera E, Sweeney C, Willey J, et al. Breast cancer patient perception of the helpfulness of a prompt sheet versus a general information sheet during outpatient consultation: a randomized, controlled trial. J Pain Symptom Manage. 2003;25:412-419.
53. Petrisek AC, Laliberte L, Allen SM, Mor V. The treatment decision-making process: age differences in a sample of women recently diagnosed with non recurrent, early-stage breast cancer. Gerontologist. 1997;37:598-608.
54. Hann DM, Baker F, Denniston MM. Oncology professionals' communication with cancer patients about complementary therapy: a survey. Comp Ther Med. 2003;11:184-190.
55. Roberts CS, Baker F, Hann D, et al. Patient-physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol. 2005;23:35-60.
56. Dog T, Riley D, Carter T. Traditional and alternative therapies for breast cancer. Altern Ther. 2001;7:136-149.
57. Angell M, Kassorer JP. Alternative medicine: the risks of untested and unregulated remedies. N Engl J Med. 1998;339:839-841.
58. Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002;137:889-903.